T1D Fund
By the Numbers
18M
living with T1D globally1
<30%
of people with T1D
meet target A1c2
$90B
annual global economic impact3
1.6M
people living with T1D in the U.S.4
$45.5B
immunology market by 2022
including T1D 5
Our Team
A skilled team of investment professionals and volunteers with diverse knowledge in science, healthcare and technology.
Meet The TeamHow We Invest
A holistic approach with the added benefits of the knowledge and resources of our parent company, JDRF.
Learn MoreNews and Press
By using a venture philanthropy model, the T1D Fund is uniquely positioned to create an investment market in T1D.
[The Fund] is different because it's looking for viability and commercial uptake whereas a basic research grant is just about the learning. To advance the mission of JDRF we need both.